Cargando…

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

Detalles Bibliográficos
Autores principales:	Catrina, AI, Makrygiannakis, D, af Klint, E, Catrina, SB, Ernestam, S, Klareskog, L, Ulfgren, AK
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834080/ http://dx.doi.org/10.1186/ar1602

Ejemplares similares

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL
por: Chatzidionysiou, Katerina, et al.
Publicado: (2021)

Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium
por: Ulfgren, A-K, et al.
Publicado: (2002)

Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium
por: Korotkova, M, et al.
Publicado: (2004)

Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
por: Lindberg, Johan, et al.
Publicado: (2006)

Increased apoptosis level in late stages of rheumatoid arthritis correlates with macrophage number
por: Catrina, AI, et al.
Publicado: (2001)

Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids
por: Gheorghe, Karina Roxana, et al.
Publicado: (2009)

Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis
por: Makrygiannakis, Dimitrios, et al.
Publicado: (2008)

Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis
por: Makrygiannakis, Dimitrios, et al.
Publicado: (2012)

Evaluation of arthroscopy and macroscopic scoring
por: af Klint, Erik, et al.
Publicado: (2009)

The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
por: Lindberg, Johan, et al.
Publicado: (2010)

Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis
por: Kurz, Katharina, et al.
Publicado: (2015)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study
por: Sundberg, Erik, et al.
Publicado: (2008)

Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology
por: Lindberg, Johan, et al.
Publicado: (2006)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Heterogeneity in cytokine profile after intra-articular steroid treatment
por: AfKlint, ENG, et al.
Publicado: (2002)

Patterns of gene expression in rheumatoid arthritis synovial tissue: inter-patient variability greater then intra-patient variability in a small study
por: Lindberg, J, et al.
Publicado: (2005)

Intra-articular steroid treatment reduces synovial HMGB1 but not IL-1 expression in chronic arthritis
por: Grundtman, C, et al.
Publicado: (2004)

Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate
por: Revu, Shankar, et al.
Publicado: (2013)

Distinct Fluorescence Optical Imaging Patient Clusters Emerge for Seropositive and Seronegative Rheumatoid Arthritis
por: Kisten, Yogan, et al.
Publicado: (2023)

Effects of anti-rheumatic treatments on the prostaglandin E(2 )biosynthetic pathway in synovial tissue and synovial fluid cells from patients with rheumatoid arthritis
por: Korotkova, M, et al.
Publicado: (2005)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

The Effects of `Pulse' Corticosteroids on Mediators of Inflammation and Joint Damage in the Rheumatoid Synovium
por: Youssef, Peter
Publicado: (2000)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

RANK and RANKL expression in rheumatoid arthritis synovium and lymph nodes as markers of dendritic cell – T cell interactions
por: Page, G, et al.
Publicado: (2004)

Association of salivary RANKL and osteoprotegerin levels with periodontal health
por: Ochanji, A. A., et al.
Publicado: (2017)

Three-dimensional spatial transcriptomics uncovers cell type localizations in the human rheumatoid arthritis synovium
por: Vickovic, Sanja, et al.
Publicado: (2022)

The Synovium in Rheumatoid Arthritis
por: Hitchon, Carol A, et al.
Publicado: (2011)

Differential gene expression and protein expression levels of MMP and TIMP molecules in response to glucocorticoid treatment in arthritic patients
por: Andersson, T, et al.
Publicado: (2004)

Autoimmune Responses in the Rheumatoid Synovium
por: Toes, Rene E. M, et al.
Publicado: (2009)

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
por: Irtyuga, Olga, et al.
Publicado: (2017)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Regulation of neurite growth by tumour necrosis superfamily member RANKL
por: Gutierrez, Humberto, et al.
Publicado: (2013)

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis
por: de Hair, MJH, et al.
Publicado: (2014)

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
por: van Kuijk, A W R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_elvkjftanmiuo3vrrs0ioua6v0